Why Penny Stock VYNE Therapeutics Is Skyrocketing Today?

By: via Benzinga
VYNE Therapeutics Inc(NASDAQ: VYNE) announced that the first vitiligo patienthad been dosedin a Phase 1a/b trial of ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.